Infectious Diseases (except HIV/AIDS)

  1. Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients

    1. Simeon Schietzel
    2. Manuel Anderegg
    3. Andreas Limacher
    4. Alexander Born
    5. Michael P Horn
    6. Britta Maurer
    7. Cedric Hirzel
    8. Daniel Sidler
    9. Matthias B Moor

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Equivalence of saliva RT-qPCR testing to nasal-throat/nasopharyngeal swab testing in the general practitioner’s setting to detect SARS-CoV-2

    1. Ilse Jonckheere
    2. Liesbeth Faes
    3. Yarah Overmeire
    4. An De Vleeschauwer
    5. Laura Vanden Daele
    6. Nathalie Van Bruaene
    7. Ilse Vandecandelaere
    8. Britt Merlaen
    9. Joannes van Cann
    10. Jo Vandesompele

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Human seasonal coronavirus neutralization and COVID‐19 severity

    1. David A. Wells
    2. Diego Cantoni
    3. Martin Mayora‐Neto
    4. Cecilia Di Genova
    5. Alexander Sampson
    6. Matteo Ferrari
    7. George Carnell
    8. Angalee Nadesalingam
    9. Peter Smith
    10. Andrew Chan
    11. Gianmarco Raddi
    12. Javier Castillo‐Olivares
    13. Helen Baxendale
    14. Nigel Temperton
    15. Jonathan L. Heeney

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Mini-XT, a miniaturized tagmentation-based protocol for efficient sequencing of SARS-CoV-2

    1. Marc Fuchs
    2. Clara Radulescu
    3. Miao Tang
    4. Arun Mahesh
    5. Deborah Lavin
    6. Syed Umbreen
    7. James McKenna
    8. Mark Smyth
    9. Eilís McColgan
    10. Zoltan Molnar
    11. Chris Baxter
    12. Timofey Skvortsov
    13. Aditi Singh
    14. Fiona Rogan
    15. Julia Miskelly
    16. Stephen Bridgett
    17. Derek Fairley
    18. David A. Simpson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Adaptive data-driven age and patch mixing in contact networks with recurrent mobility

    1. Jesse Knight
    2. Huiting Ma
    3. Amir Ghasemi
    4. Mackenzie Hamilton
    5. Kevin Brown
    6. Sharmistha Mishra

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Reduced amplification efficiency of the RNA-dependent-RNA-polymerase target enables tracking of the Delta SARS-CoV-2 variant using routine diagnostic tests

    1. Ziyaad Valley-Omar
    2. Gert Marais
    3. Arash Iranzadeh
    4. Michelle Naidoo
    5. Stephen Korsman
    6. Tongai Maponga
    7. Hannah Hussey
    8. Mary-Ann Davies
    9. Andrew Boulle
    10. Deelan Doolabh
    11. Mariska Laubscher
    12. Justyna Wojno
    13. J.D. Deetlefs
    14. Jean Maritz
    15. Lesley Scott
    16. Nokukhanya Msomi
    17. Cherise Naicker
    18. Houriiyah Tegally
    19. Tulio de Oliveira
    20. Jinal Bhiman
    21. Carolyn Williamson
    22. Wolfgang Preiser
    23. Diana Hardie
    24. Nei-yuan Hsiao

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial

    1. Laurence Chu
    2. Keith Vrbicky
    3. David Montefiori
    4. Wenmei Huang
    5. Biliana Nestorova
    6. Ying Chang
    7. Andrea Carfi
    8. Darin K. Edwards
    9. Judy Oestreicher
    10. Holly Legault
    11. Frank J. Dutko
    12. Bethany Girard
    13. Rolando Pajon
    14. Jacqueline M. Miller
    15. Rituparna Das
    16. Brett Leav
    17. Roderick McPhee

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Effect of common maintenance drugs on the risk and severity of COVID-19 in elderly patients

    1. Kin Wah Fung
    2. Seo H. Baik
    3. Fitsum Baye
    4. Zhaonian Zheng
    5. Vojtech Huser
    6. Clement J. McDonald

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study

    1. Katia J Bruxvoort
    2. Lina S Sy
    3. Lei Qian
    4. Bradley K Ackerson
    5. Yi Luo
    6. Gina S Lee
    7. Yun Tian
    8. Ana Florea
    9. Michael Aragones
    10. Julia E Tubert
    11. Harpreet S Takhar
    12. Jennifer H Ku
    13. Yamuna D Paila
    14. Carla A Talarico
    15. Hung Fu Tseng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations

    1. Elizabeth M. Anderson
    2. Shuk Hang Li
    3. Moses Awofolaju
    4. Theresa Eilola
    5. Eileen Goodwin
    6. Marcus J. Bolton
    7. Sigrid Gouma
    8. Tomaz B. Manzoni
    9. Philip Hicks
    10. Rishi R. Goel
    11. Mark M. Painter
    12. Sokratis A. Apostolidis
    13. Divij Mathew
    14. Debora Dunbar
    15. Danielle Fiore
    16. Amanda Brock
    17. JoEllen Weaver
    18. John S. Millar
    19. Stephanie DerOhannessian
    20. Allison R. Greenplate
    21. Ian Frank
    22. Daniel J. Rader
    23. E. John Wherry
    24. Paul Bates
    25. Scott E. Hensley

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 288 of 716 Next